Man Dies After Second Dose of Moderna Following Vaccine-Linked Blood Clotting Disease, Doctors Say • Protecting Children’s Health

Defender experienced censorship on many social channels. Be sure to keep in touch with news that matters subscribe to our top news of the day. It’s free.

Doctors in Pennsylvania reports a case in a U.S. patient developed blood to blood after which Moderna was received Covid vaccine.

In a case report, published in Annals of Internal Medicine June 29, healthcare professionals at the Allegheny Health Network in Pittsburgh say a 65-year-old man came to the hospital with a serious blood clot known as thrombosis with thrombocytopenia (TTS) It was only 10 days after receiving his second dose of Moderna vaccine.

Two days later, the unnamed patient died, with doctors concluding that his symptoms were consistent with vaccine -induced breakdown, also known as VITT.

Human treatment providers have not known about VITT before, so the person does not receive specialist treatment given to people suffering from VITT, instead being treated with heparin.

“If we had suspected VITT or TTS before, we would have treated the patient differently,” the doctors wrote.

Even if the person suffers from chronic hypertension and high cholesterol levels, doctors do not identify other causes of bloating, including SARS-CoV-2 infection, other infections, immune thrombocytopenia or thrombotic thrombocytopenic purpura.

“The distribution of thrombosis, especially cerebral venous sinus thrombosis, is characteristic of VITT or TTS,” according to doctors.

Doctors said their findings “fulfilled the definition of an interim case of VITT or TTS” set by the Centers for Disease Control and Prevention (CDC) and the Brighton Collaboration and additional blood tests confirmed- on the likelihood associated with the vaccine. Doctors say they believe this is the first reported case of hemorrhage following an mRNA vaccine, though thousands of reported cases at the CDC’s Vaccine Bad Vacation Reporting System (VAERS).

While doctors call their evidence for VITT “strong,” they warn other causes of bloating cannot be ruled out.

Doctors at Allegheny Health say their research “complicates” the theories that earlier cases of eruption were caused only by adenovirus-based vaccines, as some experts once said. avidly.

Experts have long warned mRNA vaccines can cause hemorrhage.

A VAERS study, which used search criteria including reports of blood clots associated with blood damage diseases, yielded a total 6,787 reports for all three vaccines from Dec. 14, 2020 to June 18, 2021.

Of the 6,787 cases reported, there were 2,893 reports dedicated to Pfizer, 2,394 reports with Moderna and 1,459 reports with J&J.

As in The Defender reports April 16, even if the Johnson & Johnson and AstraZeneca COVID vaccines are under the microscope for their potential cause of blood clots, scientists have warned since December that the Pfizer and Moderna vaccines have similar risks .

Last Dec. 8, 2020, before receiving any COVID vaccine Emergency Use Permit in the US, J. Patrick Whelan, MD, Ph.D., WROTE the U.S. Food and Drug Administration (FDA) on the potential for COVID vaccines to “cause microvascular and blood damage throughout the body including the brain, heart, liver and kidney, in ways not tested in trials in safety. “

In a study published by Oxford University, the researchers found the number of people developing cerebral venous sinus thrombosis (CVST) blood after COVID vaccines was similar for Pfizer, Moderna and AstraZeneca.

According to an Oxford study, 4 in 1 million people experience CVST two weeks after vaccination with the Pfizer or Moderna vaccine, compared with 5 in 1 million people who develop the condition after getting the AstraZeneca vaccine. .

Although researchers found an even greater increase in blood pressure in infected people COVID, the incidences of blood clots following vaccines are much higher than the experience of 0.41 – a strong signal that vaccines have a specific risk.

A study published in February of Journal of Hematology examined thrombocytopenia following vaccination by Pfizer and Moderna in response to the death of a 56-year-old Florida doctor – the first known patient to die from a cerebral hemorrhage after receiving Pfizer vaccine.

After reviewing 20 case reports of patients suffering from hemorrhage following vaccination – including 17 pre -existing thrombocytopenia – and analyzing data from U.S. health agencies, VAERS and treatment providers, researchers behind the study in the Journal of Hematology. inseparable the possibility that Pfizer and Moderna vaccines have the potential to activate ITP. They recommend extra vigilance.

In April, the Association of American Physicians and Surgeons (AAPS) notified the FDA that mRNA products, through spike proteins, may have “potential to cause microvascular damage [inflammation and small blood clots called microthrombi] in the brain, heart, liver and kidney in ways not tested in safety tests. “The FDA did not respond.

AAPS identified at least 37 people at the time who developed a rare platelet disease after receiving the Pfizer or Moderna shot.

As in The Defender reports June 23, a group of Israeli researchers said they began studying a possible link between Pfizer’s vaccine and thrombotic thrombocytopenic purpura – a rare disease that causes blood clots in the small blood vessels – following reports of a sudden rise in cases across Israel. Pfizer, like Moderna, uses mRNA technology.

Ongoing reports on blood to blood with the AstraZeneca and J&J vaccine urges many countries to ban shooting or restrict the use of specific age groups, with Denmark was chosen to extend the suspension on June 25.

Even if the AstraZeneca vaccine has not yet been approved in the U.S., U.S. health officials have previously stopped shooting J&J because of reports of blood clots, but continued its launch in April with a warning of rare blood clots.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *